UVA-Riboflavin Crosslinking
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UVA-Riboflavin Crosslinking, covering 2011-03-29 to 2011-03-29. Get the full timeline:
Most recent: Clinical Trial Update: UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia [Phase 2]